-
[1]
Zhan Zhang, Xiaochen Li, Wei Zhang, Zheng-Li Shi, Zhishui Zheng, Tao Wang, 2020: Clinical Features and Treatment of 2019-nCov Pneumonia Patients in Wuhan: Report of A Couple Cases, Virologica Sinica, 35, 330-336. doi: 10.1007/s12250-020-00203-8
-
[2]
Wentao Zhu, Yuyuan Huang, Jian Gong, Lingzhi Dong, Xiaojie Yu, Haiyun Chen, Dandan Li, Libo Zhou, Jing Yang, Shan Lu, 2023: A novel bat coronavirus with a polybasic furin-like cleavage site, Virologica Sinica, 38, 344-350. doi: 10.1016/j.virs.2023.04.009
-
[3]
Zezhong Liu, Shuai Xia, Xinling Wang, Qiaoshuai Lan, Wei Xu, Qian Wang, Shibo Jiang, Lu Lu, 2020: Inefficiency of Sera from Mice Treated with Pseudotyped SARS-CoV to Neutralize 2019-nCoV Infection, Virologica Sinica, 35, 340-343. doi: 10.1007/s12250-020-00214-5
-
[4]
李德山, D.Cavanagh, 1992: Cleavage of the Spike Protein and Cytopathogenesis of Avian Infectious Bronchitis Virus, Virologica Sinica, 7, 436-.
-
[5]
Ke Wang, Yu Pan, Dianbing Wang, Ye Yuan, Min Li, Yuanyuan Chen, Lijun Bi, Xian-En Zhang, 2023: Altered hACE2 binding affinity and S1/S2 cleavage efficiency of SARS-CoV-2 spike protein mutants affect viral cell entry, Virologica Sinica, 38, 595-605. doi: 10.1016/j.virs.2023.06.005
-
[6]
Huiting Chen, Zhaozhong Zhu, Ye Qiu, Xingyi Ge, Heping Zheng, Yousong Peng, 2022: Prediction of coronavirus 3C-like protease cleavage sites using machine-learning algorithms, Virologica Sinica, 37, 437-444. doi: 10.1016/j.virs.2022.04.006
-
[7]
Peng Zhou, Zhenggang Han, Lin-Fa Wang, Zhengli Shi, 2013: Identification of Immunogenic Determinants of the Spike Protein of SARS-like Coronavirus, Virologica Sinica, 28, 92-96. doi: 10.1007/s12250-013-3292-y
-
[8]
Leike Zhang, Jia Liu, Ruiyuan Cao, Mingyue Xu, Yan Wu, Weijuan Shang, Xi Wang, Huanyu Zhang, Xiaming Jiang, Yuan Sun, Hengrui Hu, Yufeng Li, Gang Zou, Min Zhang, Lei Zhao, Wei Li, Xiaojia Guo, Xiaomei Zhuang, Xing-Lou Yang, Zheng-Li Shi, Fei Deng, Zhihong Hu, Gengfu Xiao, Manli Wang, Wu Zhong, 2020: Comparative Antiviral Efficacy of Viral Protease Inhibitors against the Novel SARS-CoV-2 In Vitro, Virologica Sinica, 35, 776-784. doi: 10.1007/s12250-020-00288-1
-
[9]
夏咸柱, 胡桂学, 谢之景, 杨松涛, , , , 2004: Cloning and Sequence Analysis of Spike Protein Gene of Canine Coronavirus Giant Panda’s Isolate*, Virologica Sinica, 19, 481-486.
-
[10]
Jingfang Mu, Yongli Zhang, Yangyang Hu, Xue Hu, Yuan Zhou, Xinwen Chen, Yun Wang, 2016: The role of viral protein Ac34 in nuclear relocation of subunits of the actin-related protein 2/3 complex, Virologica Sinica, 31, 480-489. doi: 10.1007/s12250-016-3912-4
-
[11]
Jiaming Lan, Yao Deng, Jingdong Song, Baoying Huang, Wenling Wang, Wenjie Tan, 2018: Significant Spike-Specific IgG and Neutralizing Antibodies in Mice Induced by a Novel Chimeric Virus-Like Particle Vaccine Candidate for Middle East Respiratory Syndrome Coronavirus, Virologica Sinica, 33, 453-455. doi: 10.1007/s12250-018-0064-8
-
[12]
Yuntao Wu, 2020: Compensation of ACE2 Function for Possible Clinical Management of 2019-nCoV-Induced Acute Lung Injury, Virologica Sinica, 35, 256-258. doi: 10.1007/s12250-020-00205-6
-
[13]
Ling Tao, JianJun Chen, Jin Meng, Yao Chen, Hongxia Li, Yan Liu, Zhenhua Zheng, Hanzhong Wang, 2013: Enhanced Protective Efficacy of H5 Subtype Influenza Vaccine with Modification of the Multibasic Cleavage Site of Hemagglutinin in Retroviral Pseudotypes, Virologica Sinica, 28, 136-145. doi: 10.1007/s12250-013-3326-5
-
[14]
秦莉, 吴少庭, 王西明, 袁仕善, 黄达娜, 雷民军, 潘晖榕, 高世同, 张仁利, 屈伸, 2005: Purification of Glutathione S-transferase Fusion Proteins of SARS Coronavirus Spike Protein fragment 2 and Preparation of Anti-GST-S2 Polyclonal Antibody, Virologica Sinica, 20, 217-220.
-
[15]
王大燕, 王健伟*, 魏强, 屈建国, 洪涛, 2005: Purification of Glutathione S-transferase Fusion Proteins of SARS Coronavirus Spike Protein ragment 2 and Preparation of Anti-GST-S2 Polyclonal Antibody, Virologica Sinica, 20, 247-252.
-
[16]
Yu-xuan HOU, Cheng PENG, Zheng-gang HAN, Peng ZHOU, Ji-guo CHEN, Zheng-li SHI, 2010: Immunogenicity of the Spike Glycoprotein of Bat SARS-like Coronavirus, Virologica Sinica, 25, 36-44. doi: 10.1007/s12250-010-3096-2
-
[17]
Ning Wang, Shi-Yue Li, Xing-Lou Yang, Hui-Min Huang, Yu-Ji Zhang, Hua Guo, Chu-Ming Luo, Maureen Miller, Guangjian Zhu, Aleksei A. Chmura, Emily Emily, Ji-Hua Zhou, Yun-Zhi Zhang, Lin-Fa Wang, Peter Daszak, Zheng-Li Shi, 2018: Serological Evidence of Bat SARS-Related Coronavirus Infection in Humans, China, Virologica Sinica, 33, 104-107. doi: 10.1007/s12250-018-0012-7
-
[18]
Pengfei Chen, Xiangmei Tan, Mengqin Lao, Xia Wu, Xiongwei Zhao, Shuting Zhou, Jiarong Yu, Junrui Zhu, Lingxue Yu, Wu Tong, Fei Gao, Hai Yu, Changlong Liu, Yifeng Jiang, Guangzhi Tong, Yanjun Zhou, 2021: The Novel PRRSV Strain HBap4-2018 with a Unique Recombinant Pattern Is Highly Pathogenic to Piglets, Virologica Sinica, 36, 1611-1625. doi: 10.1007/s12250-021-00453-0
-
[19]
Yanxing Cai, Wei Xu, Chenjian Gu, Xia Cai, Di Qu, Lu Lu, Youhua Xie, Shibo Jiang, 2020: Griffithsin with A Broad-Spectrum Antiviral Activity by Binding Glycans in Viral Glycoprotein Exhibits Strong Synergistic Effect in Combination with A Pan-Coronavirus Fusion Inhibitor Targeting SARS-CoV-2 Spike S2 Subunit, Virologica Sinica, 35, 857-860. doi: 10.1007/s12250-020-00305-3
-
[20]
寸韡, 马绍辉, 赵红玲, 刘龙丁, 李卫中, 王丽春, 董承红, 张莹, 王祥, 李琦涵*, 2006: Localization of HSV-I ICP22 Protein in Cells by Antibody Against a predicted Antigenic Peptide, Virologica Sinica, 21, 226-230.